A Phase I Study of Gemcitabine, Carboplatin and Lenalidomide (GCL) for Treatment of Patients With Advanced/Metastatic Urothelial Carcinoma (UC) and Other Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01352962

Title field or adapter rule

{'original_value': 'A Phase I Study of Gemcitabine, Carboplatin and Lenalidomide (GCL) for Treatment of Patients With Advanced/Metastatic Urothelial Carcinoma (UC) and Other Solid Tumors', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:23.257726+00:00

Published At

2026-10-16T00:00:00+00:00

Record Updated At

2026-10-16

Source Retrieved At

2026-10-31T22:17:52.415050+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Urethral Neoplasms", "Neoplasms, Urethral", "Cancer of the Urethra", "Urethral Cancer"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-16", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT01352962"

protocolSection.identificationModule.officialTitle

"A Phase I Study of Gemcitabine, Carboplatin and Lenalidomide (GCL) for Treatment of Patients With Advanced/Metastatic Urothelial Carcinoma (UC) and Other Solid Tumors"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Urethral Neoplasms (protocolSection.conditionsModule.conditions)
• Neoplasms, Urethral (protocolSection.conditionsModule.conditions)
• Cancer of the Urethra (protocolSection.conditionsModule.conditions)
• Urethral Cancer (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Arm 1', 'Arm 2'], 'description': '1,000mg/m2 IVPB over 30 min x 1', 'name': 'Gemcitabine', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Arm 1', 'Arm 2'], 'description': 'AUC 5\\*\\* IVPB over 30 min x 1', 'name': 'Carboplatin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Arm 1', 'Arm 2'], 'description': 'Escalating Doses starting at 2.5 po daily up to 25 mg po daily until MTD is reached.', 'name': 'Lenalidomide', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Gemcitabine (protocolSection.armsInterventionsModule.interventions[].name)
• Carboplatin (protocolSection.armsInterventionsModule.interventions[].name)
• Lenalidomide (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.